KCM
EXAS

Kennedy Capital Management’s Exact Sciences EXAS Stock Holding History

Kennedy Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-61,982
Closed -$6.29M – 550
2025
Q4 		$6.29M Buy
61,982
+180
+0.3% +$14.5K 0.13% 247
2025
Q3 		$3.38M Sell
61,802
-447
-0.7% -$22.3K 0.07% 360
2025
Q2 		$3.31M Sell
62,249
-18,619
-23% -$946K 0.08% 357
2025
Q1 		$3.5M Sell
80,868
-66,591
-45% -$3.37M 0.08% 344
2024
Q4 		$8.29M Buy
147,459
+13,600
+10% +$846K 0.18% 177
2024
Q3 		$9.12M Buy
133,859
+98,824
+282% +$5.58M 0.2% 155
2024
Q2 		$1.48M Buy
+35,035
New +$1.93M 0.03% 546
2022
Q2 		– Sell
-4,804
Closed -$336K – 610
2022
Q1 		$336K Buy
4,804
+1,007
+27% +$73.6K 0.01% 572
2021
Q4 		$296K Sell
3,797
-232
-6% -$20.5K 0.01% 591
2021
Q3 		$385K Sell
4,029
-175
-4% -$18.5K 0.01% 600
2021
Q2 		$523K Buy
4,204
+141
+3% +$16.8K 0.01% 575
2021
Q1 		$535K Buy
4,063
+607
+18% +$83.1K 0.01% 594
2020
Q4 		$458K Buy
3,456
+704
+26% +$85.1K 0.01% 590
2020
Q3 		$281K Buy
2,752
+2
+0.1% +$173 0.01% 622
2020
Q2 		$239K Buy
+2,750
New +$220K 0.01% 636

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Kennedy Capital Management's EXAS Position: Q1 2026 in Review

Kennedy Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 61,982 shares — an estimated $6.29M sold.

Kennedy Capital Management first reported a position in EXAS in Q2 2020 and held it in 15 quarters. The position peaked at $9.12M in Q3 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Kennedy Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Kennedy Capital Management sold 61,982 Exact Sciences shares in Q1 2026, an estimated $6.29M.
  • Kennedy Capital Management first reported a position in Exact Sciences in Q2 2020 and held it in 15 quarters.
  • Kennedy Capital Management's Exact Sciences position peaked at $9.12M in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.